SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,811.76 |
| Enterprise Value ($M) | 2,967.61 |
| Book Value ($M) | 178.82 |
| Book Value / Share | 0.60 |
| Price / Book | 15.72 |
| NCAV ($M) | -109.26 |
| NCAV / Share | -0.37 |
| Price / NCAV | -25.74 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.17 |
| Return on Assets (ROA) | -0.13 |
| Return on Equity (ROE) | -0.65 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.42 |
| Current Ratio | 3.15 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 498.47 |
| Assets | 786.56 |
| Liabilities | 607.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | William Blair Investment Management, Llc | 5.30 | ||
| 13G/A | Avoro Capital Advisors LLC | 7.80 | -15.42 | |
| 13G/A | Redmile Group, LLC | 5.10 | -29.97 | |
| 13G/A | Wellington Management Group Llp | 8.08 | 57.76 | |
| 13G/A | Jpmorgan Chase & Co | 4.30 | -26.73 | |
| 13G/A | Perceptive Advisors Llc | 9.60 | 1.50 | |
| 13G/A | Vanguard Group Inc | 9.72 | 7.36 | |
| 13G/A | BlackRock, Inc. | 7.80 | 14.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 263,952 | 1,450,464 | 18.20 | |
| 159,016 | 1,193,465 | 13.32 | |
| 349,713 | 1,958,442 | 17.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FATE – Fate Therapeutics, Inc. | FBLG – FibroBiologics, Inc. |
| FHTX – Foghorn Therapeutics Inc. | FULC – Fulcrum Therapeutics, Inc. |
| GANX – Gain Therapeutics, Inc. |